XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
3 Months Ended
Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Restricted Stock Awards (“RSAs”) and Restricted Stock Units (“RSUs”)
We issue RSAs and RSUs to participants in our equity plans in the form of time-based RSAs and RSUs and performance-based RSAs and RSUs.
Compensation cost related to RSA and RSU grants was $1.7 million and $1.6 million for the three months ended April 1, 2023 and March 26, 2022, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.
The following table summarizes our RSA and RSU activity for the three months ended April 1, 2023:
Shares Weighted
Average
Fair Value
Balance at December 31, 2022238,922$92.07 
Granted93,944$98.02 
Vested(59,382)$77.02 
Canceled(8,392)$81.56 
Balance at April 1, 2023265,092$97.88 
For the three months ended April 1, 2023, we granted 29,399 performance-based RSUs with a grant date fair value of $113.15 per share. For the three months ended March 26, 2022, we granted 23,995 performance-based RSUs with a grant date fair value of $111.31 per share.
As of April 1, 2023, there was $20.2 million of unrecognized compensation cost related to unvested RSA and RSU grants that is expected to be recognized over a weighted average period of 2.6 years.
Stock Options
We grant stock options to participants in our equity plans. Compensation cost related to stock option grants was $0.4 million for both the three months ended April 1, 2023 and March 26, 2022, and was included as selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.
The following table summarizes our stock option activity for the three months ended April 1, 2023:
Shares Weighted
Average
Price
Weighted
Average
Remaining
Term
(years)
Aggregate
Intrinsic
Value
 (in thousands)
Balance at December 31, 2022268,119$84.03 
Granted76,784$91.28 
Canceled(1,113)$96.36 
Exercised(21,702)$72.85 
Balance at April 1, 2023322,088$86.47 6.1$1,935 
Exercisable at April 1, 2023133,913$80.31 5.0$1,398 
As of April 1, 2023, there was $5.7 million of unrecognized compensation cost related to unvested stock options that is expected to be recognized over a weighted average period of 3.2 years.